Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions for disease elements in calcium pyrophosphate crystal deposition (CPPD).
Journal: Annals of the rheumatic diseases
Published: March 18, 2026
Efficacy and Safety of Nanoencapsulated Sirolimus Plus Pegadricase: Results From the Randomized, Placebo-Controlled Phase 3 Trials.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 24, 2025
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Journal: Rheumatology (Oxford, England)
Published: February 08, 2023
Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.
Journal: Rheumatology and therapy
Published: January 04, 2023
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of Response.
Journal: Current rheumatology reports
Published: December 06, 2021
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Journal: Annals of the rheumatic diseases
Published: September 30, 2020
Use of Pre-Infusion Serum Uric Acid Levels as a Biomarker for Infusion Reaction Risk in Patients on Pegloticase.
Journal: Rheumatology and therapy
Published: February 11, 2019
Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 19, 2019
Update on imaging in gout: contrasting and comparing the role of dual-energy computed tomography to traditional diagnostic and monitoring techniques.
Journal: Clinical and experimental rheumatology
Published: September 13, 2018
Infusion-related reactions with pegloticase, a recombinant uricase for the treatment of chronic gout refractory to conventional therapy.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 25, 2014
Last Updated: 09/26/2026